FibroBiologics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that FibroBiologics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($5.78M) | Oct 31, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($4.66M) | Oct 31, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($4.66M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($4.97M) | May 14, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($4.97M) | Jul 31, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($4.97M) | Oct 31, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($500.0K) | Oct 31, 2025 |
| Q3 | 2025 | Jun 30, 2024 | $898.0K | Oct 31, 2025 |
| Q2 | 2025 | Jun 30, 2024 | $898.0K | Jul 31, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($8.46M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($8.46M) | May 14, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($8.46M) | Oct 31, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.19M) | Nov 12, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($2.16M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.16M) | Aug 7, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($2.42M) | May 14, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($2.42M) | Nov 12, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($2.42M) | Aug 7, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($5.04M) | Oct 31, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($4.49M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($4.53M) | May 14, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($3.35M) | Oct 31, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($3.22M) | Jul 31, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($3.45M) | May 14, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.05M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.09M) | Aug 7, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($2.27M) | May 14, 2024 |